April 27, 2017 / 11:48 AM / in 8 months

Drugmaker AbbVie's profit rises 26.4 pct

April 27 (Reuters) - AbbVie Inc reported a 26.4 percent jump in quarterly profit on Thursday, helped by higher demand for its top-selling treatment, Humira.

The U.S. drugmaker’s net profit rose to $1.71 billion, or $1.06 per share, in the first quarter ended March 31, from $1.35 billion, or 83 cents per share, a year earlier.

Net revenue rose to $6.54 billion from $5.96 billion.

Reporting by Natalie Grover in Bengaluru; Editing by Sriraj Kalluvila

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below